{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:34:04Z","timestamp":1785382444482,"version":"3.55.0"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"44","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,21]]},"DOI":"10.1093\/eurheartj\/ehx533","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T15:15:15Z","timestamp":1503414915000},"page":"3293-3295","source":"Crossref","is-referenced-by-count":18,"title":["Safety of non-steroidal anti-inflammatory drugs"],"prefix":"10.1093","volume":"38","author":[{"given":"William S","family":"Weintraub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,12]]},"reference":[{"key":"key\n\t\t\t\t20180129102707_ehx533-B1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1365-2044.2000.01271.x","article-title":"Cyclo-oxygenase isoenzymes: physiological and pharmacological role","volume":"55","author":"Kam","year":"2000","journal-title":"Anaesthesia"},{"key":"key\n\t\t\t\t20180129102707_ehx533-B2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/0003-4819-121-4-199408150-00011","article-title":"Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis","volume":"121","author":"Johnson","year":"1994","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180129102707_ehx533-B3","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3949\/ccjm.68.11.963","article-title":"Cox-2 inhibitors and cardiovascular risk: we defend our data and suggest caution","volume":"68","author":"Mukherjee","year":"2001","journal-title":"Cleve Clin J Med"},{"key":"key\n\t\t\t\t20180129102707_ehx533-B4","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1073\/pnas.90.24.11693","article-title":"Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase","volume":"90","author":"Mitchell","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180129102707_ehx533-B5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(98)12154-2","article-title":"COX-2 inhibitors","volume":"353","author":"Hawkey","year":"1999","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180129102707_ehx533-B6","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180129102707_ehx533-B7","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180129102707_ehx533-B8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180129102707_ehx533-B9","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180129102707_ehx533-B10","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","article-title":"Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis","volume":"375","author":"Nissen","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180129102707_ehx533-B11","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1093\/eurheartj\/ehx508","article-title":"Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis","volume":"38","author":"Ruschitzka","year":"2017","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/38\/44\/3293\/23686996\/ehx533.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T13:42:57Z","timestamp":1570023777000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/38\/44\/3293\/4157350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,12]]},"references-count":11,"journal-issue":{"issue":"44","published-online":{"date-parts":[[2017,9,12]]},"published-print":{"date-parts":[[2017,11,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehx533","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11]]},"published":{"date-parts":[[2017,9,12]]}}}